Volume : VII, Issue : XII, December - 2017

Role of Intravitreal Bevacizumab in the treatment of Macular oedema due to Retinal vein occlusion

Dr. G. Premalatha, Dr. M. Sri Ramachandra Murthy

Abstract :

 AIM:  To study the effectiveness of intravitreal Bevacizumab ( Avastin) in macular oedema due to retinal vein occlusion

 

STUDY: Hospital based interventional study.

              Sample size: 50 patients

 

METHODS: All the  patients with retinal vein occlusion (CRVO & BRVO) with  centre involving macular oedema of CMT >300micronswere taken in the study, the patients with media opacities and other causes for macular edema were excluded.

 Patients who met inclusion criteria received IVA 1.25mg in 0.05 ml.

 BCVA, ophthalmic examination, OCT–Macula were performed at baseline and after 1 month post injection.

 Re–injections were given if OCT–Macula showed persistent or recurrent macular oedema(ME) in  follow–up visits.

 Each were evaluated at follow–up visits monthly till 6months.The results are analyzed according to OCT values.

 

CONCLUSION: Intravitreal Bevacizumab (IVA) seems to be safe and effective in treatment of  RVO associated with macular oedmea in reducing the CMT, however higher randomised controlled trails are required to establish its safety.

 

Keywords :

Article: Download PDF   DOI : 10.36106/ijar  

Cite This Article:

Dr.G.PREMALATHA, Dr.M.SRI RAMACHANDRA MURTHY, Role of Intravitreal Bevacizumab in the treatment of Macular oedema due to Retinal vein occlusion, INDIAN JOURNAL OF APPLIED RESEARCH : Volume-7 | Issue-12 | December-2017

Number of Downloads : 716

References :